"The Report Global
Depression Drugs Market 2015-2019 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
Description
About depression drugs
According to the WHO,
depression is a common mental disorder that contributes significantly
to the global burden of disease. It affects people across communities
worldwide. It is characterized by sadness, loss of interest or
pleasure, feelings of guilt or low self-worth, disturbed sleep or
appetite, feelings of tiredness, and poor concentration. Depression
can be roughly categorized into six different types. An individual
with severe depression can have suicidal thoughts and behaviors.
According to a 2012 estimate by the WHO, about 3,000 suicides take
place each day, resulting in more than a million deaths each year.
Depression can be recurrent and can be severely debilitating.
Patients with mild depression can be treated with medications, but in
cases of moderate or severe depression, the patient needs both
medication and professional psychotherapy in the form of counseling.
Technavio's analysts forecast
the global depression drugs market to grow at a CAGR of 5.25% over
the period 2014-2019.
Covered in this report
This report covers the present
scenario and the growth prospects of the global depression drugs
market for the period 2015-2019. To calculate the market size, the
report considers revenue generated from the sales of various drugs
used for the treatment of depression. The global depression drugs
market is segmented based on the mechanism of action of the drugs
used to treat depression, as mentioned below:
Tricyclic antidepressants
Serotonin-norepinephrine
reuptake inhibitors
Selective serotonin
reuptake inhibitors
Monoamine oxidase
inhibitors
Technavio's report, Global
Depression Drugs Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from industry experts. The
report covers the Americas, EMEA, and APAC; it also covers the market
landscape and its growth prospects in the coming years. The report
also includes a discussion of the key vendors operating in this
market.
View Full Report at
http://www.marketresearchreports.biz/analysis/287684
Key regions
Americas
APAC
EMEA
Key vendors
Actavis
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Pfizer
Other prominent vendors
Abbott Laboratories
Addex Therapeutics
Alkermes
AstraZeneca
Aurobindo Pharma
Market driver
Rise in patient population
For a full, detailed list,
view our report
Market challenge
Threat of expiry of
patents
For a full, detailed list,
view our report
Market trend
Growing public awareness
For a full, detailed list,
view our report
Download
Sample copy of this Report at
Table of Content
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research
Methodology
06. Introduction
07. Disorder Overview
08. Market Landscape
09. Market Segmentation by
Mechanism of Action
10. Geographical Segmentation
11. Pipeline Portfolio
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and
Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
20. Key Vendor Analysis
21. Other Reports in this
Series
Browse
Latest News at http://www.marketresearchreports.biz/articles
About Us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Browse Our Press Releases
by Prnewswire:
Browse Press Releases by
Prweb :
Contact Us
Office:
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
No comments:
Post a Comment